NCT07284823 Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease
| NCT ID | NCT07284823 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cionic, Inc. |
| Condition | Parkinson Disease (PD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-12 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-12 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research will investigate the safety and usability of the Cionic Neural Sleeve Multistim System for Parkinson's Disease.
Eligibility Criteria
Inclusion Criteria: * Self-reported gait impairment * Have access to a smartphone with iOS or Android operating system with Bluetooth capabilities and internet connection * Ability to walk with or without an assistive device for up to 1 minute * Leg measurements within sizing range of the Cionic Neural Sleeve Exclusion Criteria: * Daily occurrence of falls * Implanted demand-type cardiac pacemaker or defibrillator * Malignant tumor or existing thrombosis in the leg * Fracture or dislocation in the leg that could be adversely affected by motion from stimulation
Frequently Asked Questions
Who can join the NCT07284823 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, up to 75 Years, studying Parkinson Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07284823 currently recruiting?
Yes, NCT07284823 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cionic, Inc. to inquire about joining.
Where is the NCT07284823 trial being conducted?
This trial is being conducted at Carlsbad, United States, San Francisco, United States.
Who is sponsoring the NCT07284823 clinical trial?
NCT07284823 is sponsored by Cionic, Inc.. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.